Effects of hydrogen peroxide on mitochondrial enzyme function studied in situ in rat heart myocytes.
Our previous work indicated that energy transduction, as measured by myocyte respiration, was inhibited by hydrogen peroxide, but the mitochondrial membrane potential was relatively unaffected. Therefore, we determined in the present study the critical steps in mitochondrial energy transduction by measuring the sensitivity to hydrogen peroxide of NADH-CoQ reductase, ATP synthase, and adenine nucleotide translocase in situ in myocytes. Adult rat heart cells were isolated using collagenase and incubated in the presence of 0.1-10 mM hydrogen peroxide for 30 min. Activities of NADH-CoQ reductase and oligomycin-sensitive ATP synthase were assayed enzymatically with sonicated myocytes, and adenine nucleotide translocase activities were determined by atractyloside-inhibitable [14C]ADP uptake of myocytes, permeabilized by saponin. The NADH-CoQ reductase and ATP synthase activities were inhibited to 77% and 67% of control, respectively, following an exposure to 10 mM hydrogen peroxide for 30 min. The adenine nucleotide translocase activities were inhibited in a concentration- and time-dependent manner and by 10 mM hydrogen peroxide to 44% of control. The dose-response relationship indicated that the translocase was the most susceptible to hydrogen peroxide among the three enzymes studied. Combined treatment of myocytes with 3-amino-1,2,4-triazole, 1,3-bis(2-chloroethyl)-1-nitrosourea and diethyl maleate (to inactivate catalase, to inhibit glutathione reductase activity, and to deplete glutathione, respectively) enhanced the sensitivity of translocase to hydrogen peroxide, supporting the view that the cellular defense mechanism is a significant factor in determining the toxicity of hydrogen peroxide. The results indicate that hydrogen peroxide can cause dysfunction in mitochondrial energy transduction, principally as the result of inhibition of adenine nucleotide translocase.
Tatsumi
T
T
Department of Physiology, Faculty of Medicine, University of Ottawa, Canada.
Kako
K J
KJ
D000244:Adenosine Diphosphate / Q000493:pharmacokinetics; D000818:Animals; D002330:Carmustine / Q000494:pharmacology; D042967:Electron Transport Complex I; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D008298:Maleates / Q000494:pharmacology; D008929:Mitochondria, Heart / Q000201:enzymology*; D000226:Mitochondrial ADP, ATP Translocases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009206:Myocardium / Q000166:cytology / Q000201:enzymology* / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism*; D009994:Osmolar Concentration; D006180:Proton-Translocating ATPases / Q000378:metabolism*; D051381:Rats; D013997:Time Factors
D008298:Maleates; D000244:Adenosine Diphosphate; D000226:Mitochondrial ADP, ATP Translocases; D006861:Hydrogen Peroxide; D009247:NADH, NADPH Oxidoreductases; D006180:Proton-Translocating ATPases; D042967:Electron Transport Complex I; C014476:diethyl maleate; D002330:Carmustine